Clinical Trials Browser

Withdrawn × repotrectinib × Clear all

NCT05828303 2025-04-01

A Phase 1 Study to Evaluate the Potential Drug Interactions Between Repotrectinib and Metformin, Digoxin, and Rosuvastatin in Patients With Advanced Solid Tumors

Phase 1 Withdrawn

Neoplasm Metastasis

NCT05828277 2023-09-26

A Phase 1 Study to Assess the Effect of Hepatic Impairment on the Pharmacokinetics of Repotrectinib in Advanced Cancer Patients

Phase 1 Withdrawn

Neoplasm Metastasis